Stockholders' Equity - Accumulated other comprehensive income/ (loss) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance		$ (839)
Other comprehensive gain/(loss), net of tax	[1]	(101)	$ (22)	$ (53)
Ending balance		(940)	(839)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		4,770	4,991	4,403	$ 4,544
Accumulated Other Comprehensive (Loss)/ Income
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Other comprehensive gain/(loss), net of tax		(101)	(22)	(53)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(940)	(839)	(817)	(764)
Derivatives Net Unrealized Losses
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Other comprehensive gain/(loss), net of tax		4	(5)	86
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		89	85	90	$ 4
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance		18	41	5
Other comprehensive gain/(loss), net of tax		44	(23)	36
Ending balance		62	18	41
Currency Translation Adjustment, Net Unrealized Losses
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance		(944)	(944)	(756)
Other comprehensive gain/(loss), net of tax		(147)	0	(188)
Ending balance		(1,091)	(944)	(944)
Benefit Plans, Actuarial Gains/ (Losses)
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance		2	(4)	(17)
Other comprehensive gain/(loss), net of tax		(2)	6	13
Ending balance		$ 0	$ 2	$ (4)

[1] Presented net of reclassification adjustments, which are not material in any period presented. Reclassification adjustments related to benefit plans are generally reclassified, as part of net periodic pension cost, into Cost of sales, Selling, general and administrative expenses, and/or Research and development expenses, as appropriate, in the Consolidated Statements of Income.